Total amount: € 0,00
Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752
Online ISSN 1827-1618
TAVI 2013: WHERE ARE WE NOW?
Schirmer J. 1, Conradi L. 1, Seiffert M. 2, Koschyk D. 2, Blankenberg S. 2, Reichenspurner H. 1, Diemert P. 2, Treede H. 1
1 Department of Cardiovascular Surgery University Heart Center Hamburg, Hamburg, Germany;
2 Department of General and , Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
Calcific aortic valve stenosis represents the most common acquired valvular heart disease in adults. Transcatheter aortic valve implantation (TAVI) has been established as a widely accepted therapeutic option in elderly and multimorbid patients with severe aortic stenosis not amenable to conventional surgery. Retrograde transfemoral and antegrade transapical approaches are commonly used for implantation. However, there are a certain number of patients who are not candidates for either approach due to poor vascular access, severe pulmonary dysfunction or other prohibitive chest pathologies. Recently, different alternative access route options have been proposed and described. These alternative access routes include approaches via the subclavian/axillary artery, the ascending aorta, the carotid artery, and the brachiocephalic artery.